Y. Kang

Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer

Yue Cai, Y. Kang, Yongbo Kang, 2021, World journal of gastroenterology.

Change in gut microbiota for eczema: Implications for novel therapeutic strategies.

W. Pan, Y. Kang, Y. Cai, 2017, Allergologia et immunopathologia.

Altered gut microbiota in RA: implications for treatment

J. Su, Y. Kang, X. Kong, 2017, Zeitschrift für Rheumatologie.

Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.

Yue Cai, Yongbo Kang, Y. Kang, 2017, The Journal of hospital infection.

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder

Yongchao Zhang, Jixiang Wang, Zhiyong Li, 2018, Neuropsychiatric disease and treatment.

Gut microbiota and allergy/asthma: From pathogenesis to new therapeutic strategies.

Y. Kang, Y. Cai, H. Zhang, 2017, Allergologia et immunopathologia.

Future prospect of faecal microbiota transplantation as a potential therapy in asthma.

Y. Kang, Y. Cai, 2018, Allergologia et immunopathologia.

Stachyose inhibits vancomycin-resistant Enterococcus colonization and affects gut microbiota in mice.

Dayong Wu, Yuanming Huang, Yu-chun Xiao, 2021, Microbial pathogenesis.